Concepedia

The Relationship Between Tumor-Infiltrating Lymphocytes, PD-L1 Expression, Driver Mutations and Clinical Outcome Parameters in Non-Small Cell Lung Cancer Adenocarcinoma in Patients with a Limited to no Smoking History

S. Mignon, Karen Willard‐Gallo, Gert Van den Eynden, Roberto Salgado, Lore Decoster, Koen M. Marien, Johan Vansteenkiste, Erik Teugels, Jacques De Grève

Pathology & Oncology Research · 2019 · 10 citations · 14 references

Open access

References

14

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

Roberto Salgado, Carsten Denkert, Sandra Demaria et al. · Annals of Oncology · 2014 · 3.1K citations · Full text

Medicine, Immunology, Oncology +16

Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors

Esra A. Akbay, Shohei Koyama, Julián Carretero et al. · Cancer Discovery · 2013 · 1.2K citations · Full text

Medicine, Immunology, Oncology +17

Programmed death ligand-1 expression in non-small cell lung cancer

Vamsidhar Velcheti, Kurt A. Schalper, Daniel Carvajal et al. · Laboratory Investigation · 2013 · 753 citations · Full text

Medicine, Cancer Biology, Oncology +14

Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer

Koichi Azuma, Keiichi Ota, Akihiko Kawahara et al. · Annals of Oncology · 2014 · 677 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Objective Measurement and Clinical Significance of TILs in Non–Small Cell Lung Cancer

Kurt A. Schalper, Jason R. Brown, Daniel Carvajal‐Hausdorf et al. · JNCI Journal of the National Cancer Institute · 2015 · 431 citations · Full text

Medicine, Immunology, Oncology +17